← Open Payments lookup

SHEFALI PATEL: Open Payments

NPI 1902488125 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,642 in 99 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $632 · 2025 $1,642

Food & beverage: $1,642
CompanyPaymentsAmount
Forte Bio-Pharma LLC27$348
Collegium Pharmaceutical, Inc.21$260
ABBVIE INC.13$258
VERTEX PHARMACEUTICALS INCORPORATED4$97
Nalu Medical, Inc.3$89
SCILEX PHARMACEUTICALS INC.5$83
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$82
PFIZER INC.4$75
Azurity Pharmaceuticals, Inc.3$65
Valinor Pharma, LLC3$51

Products named: PROLATE, QULIPTA, XTAMPZA, Belbuca, JOURNAVX, Nalu Neurostimulation System, RELISTOR, HORIZANT.

Industry payments across TX — which companies pay providers there.